Stock 600329 TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Equities

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
36.66 CNY -0.81% Intraday chart for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.79% +8.95%
May. 15 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes CI
Apr. 30 Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% MT

Business Summary

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Number of employees: 4,619

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Patent Medicine
71.0 %
5,652 68.5 % 5,836 71.0 % +3.26%
Western Medicine
20.6 %
1,783 21.6 % 1,697 20.6 % -4.84%
Other
8.2 %
796 9.7 % 673 8.2 % -15.47%
Other Business
0.2 %
18 0.2 % 16 0.2 % -9.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.5 %
8,198 99.6 % 8,161 99.5 % -0.44%
Overseas
0.5 %
34 0.4 % 45 0.5 % +33.00%

Managers

Managers TitleAgeSince
Lei Wang CEO
 Chief Executive Officer 53 22-08-21
Jian Ma DFI
 Director of Finance/CFO 46 23-07-20
Hong Zhou CTO
 Chief Tech/Sci/R&D Officer 54 12-11-30
Ming Jie Shang BRD
 Director/Board Member 55 23-02-28
Xiu Mei Guo
42 -
Mai Wang
54 -
Jian Wang IRC
 Investor Relations Contact - -
YU Zhang
51 -
Xi Xie
- -
Jian Zhang
61 -

Members of the board

Members of the board TitleAgeSince
Ping Zhang BRD
 Director/Board Member 55 19-09-29
Guat Kwang Yeo BRD
 Director/Board Member 63 Nov. 27
Jian Hua Xing BRD
 Director/Board Member 53 21-12-09
Mai Wang BRD
 Director/Board Member 54 17-07-31
Lei Wang CEO
 Chief Executive Officer 53 22-08-21
Xiu Mei Guo BRD
 Director/Board Member 42 18-12-23
Yuan Xi Wang CHM
 Chairman 46 19-12-01
Li Qing BRD
 Director/Board Member 57 21-05-16
Ming Rui Zhang CHM
 Chairman 49 21-12-27
Ming Jie Shang BRD
 Director/Board Member 55 23-02-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 200,000,000 0 0 31.14 %
Stock B 1 570,158,276 239,803,030 ( 42.06 %) 1,285,200 ( 0.2254 %)

Shareholders

NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
58.52 %
331,120,528 58.52 % 1 608 M ¥
Zhong Ou Asset Management Co., Ltd
1.458 %
8,249,081 1.458 % 40 M ¥
First Seafront Fund Management Co., Ltd.
1.290 %
7,299,839 1.290 % 35 M ¥
Fullgoal Fund Management Co., Ltd.
0.8057 %
4,559,276 0.8057 % 22 M ¥
Swee Teck Michael Tan
0.6539 %
3,700,000 0.6539 % 18 M ¥
GF Fund Management Co., Ltd.
0.4704 %
2,661,973 0.4704 % 13 M ¥
CITIC-Prudential Fund Management Co., Ltd.
0.3986 %
2,255,672 0.3986 % 11 M ¥
China Southern Asset Management Co., Ltd.
0.3720 %
2,105,259 0.3720 % 10 M ¥
China Asset Management Co., Ltd.
0.3162 %
1,789,344 0.3162 % 9 M ¥
Cinda Fund Management Co. Ltd.
0.2739 %
1,549,656 0.2739 % 8 M ¥
NameEquities%Valuation
Jinhushen Biomedical Technology Co., Ltd.
2.633 %
5,265,000 2.633 % 13 M ¥
RAM Active Investments SA
0.0923 %
184,500 0.0923 % 448 335 ¥

Company contact information

Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd.

No. 17 Baidi Road Nankai District

300193, Tianjin

+

http://en.pharm.com.cn
address Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited(600329)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Ratings for Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
36.66 CNY
Average target price
45.8 CNY
Spread / Average Target
+24.93%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+8.95% 3.43B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+38.24% 6.21B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-22.80% 4.1B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-19.98% 2.85B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-10.41% 2.29B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+46.41% 1.98B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+48.31% 1.54B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-15.56% 1.54B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-8.05% 1.53B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-20.28% 1.41B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 600329 Stock
  4. Company Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited